There are over 10 million cancer survivors today in America, and the disease is no longer considered a "death sentence."
During the past 20 years cancer survival rates have improved about 1% each year, driven by biotech and its new anti-cancer drugs. Before 1986 there were limited gains in survival rates.
Annual research spending on breast cancer – almost $14,000 for each breast cancer death - is 13x more than annual research spending on lung cancer.